Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1072

1.

Clinical and economic benefits of de-escalating stress ulcer prophylaxis therapy in the intensive care unit: A quality improvement study.

Anstey MH, Litton E, Palmer RN, Neppalli S, Tan BJ, Hawkins DJ, Krishnamurthy RB, Jacques A, Sonawane RV, Chapman AR, Norman R.

Anaesth Intensive Care. 2019 Oct 9:310057X19860972. doi: 10.1177/0310057X19860972. [Epub ahead of print] No abstract available.

PMID:
31594383
2.

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, Brichard B, Claude L, Craft A, Amler S, Gaspar N, Gelderblom H, Goldsby R, Gorlick R, Grier HE, Guinbretiere JM, Hauser P, Hjorth L, Janeway K, Juergens H, Judson I, Krailo M, Kruseova J, Kuehne T, Ladenstein R, Lervat C, Lessnick SL, Lewis I, Linassier C, Marec-Berard P, Marina N, Morland B, Pacquement H, Paulussen M, Randall RL, Ranft A, Le Teuff G, Wheatley K, Whelan J, Womer R, Oberlin O, Hawkins DS; Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators.

J Clin Oncol. 2019 Sep 25:JCO1900915. doi: 10.1200/JCO.19.00915. [Epub ahead of print]

PMID:
31553693
3.

Thyroid Cancer in the Pediatric Population.

Paulson VA, Rudzinski ER, Hawkins DS.

Genes (Basel). 2019 Sep 18;10(9). pii: E723. doi: 10.3390/genes10090723. Review.

4.

Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Mascarenhas L, Chi YY, Hingorani P, Anderson JR, Lyden ER, Rodeberg DA, Indelicato DJ, Kao SC, Dasgupta R, Spunt SL, Meyer WH, Hawkins DS.

J Clin Oncol. 2019 Sep 12:JCO1900576. doi: 10.1200/JCO.19.00576. [Epub ahead of print]

PMID:
31513481
5.

Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.

Hibbitts E, Chi YY, Hawkins DS, Barr FG, Bradley JA, Dasgupta R, Meyer WH, Rodeberg DA, Rudzinski ER, Spunt SL, Skapek SX, Wolden SL, Arndt CAS.

Cancer Med. 2019 Aug 27. doi: 10.1002/cam4.2504. [Epub ahead of print]

6.

Factors of Success for Transitioning From a Scientific Role to a Supervisory Leadership Role in a Federal Public Health Agency, 2016.

Flores AL, Risley K, Zanoni J, Welter C, Hawkins D, Pinsker E, Quintana K.

Public Health Rep. 2019 Sep/Oct;134(5):466-471. doi: 10.1177/0033354919867728. Epub 2019 Aug 14. No abstract available.

PMID:
31412217
7.

Opioid-related overdose deaths by industry and occupation-Massachusetts, 2011-2015.

Hawkins D, Roelofs C, Laing J, Davis L.

Am J Ind Med. 2019 Oct;62(10):815-825. doi: 10.1002/ajim.23029. Epub 2019 Jul 26.

PMID:
31347714
8.

Decline in the rate of occupational injuries and illnesses following the implementation of a paid sick leave law in Connecticut.

Hawkins D, Zhu J.

Am J Ind Med. 2019 Oct;62(10):859-873. doi: 10.1002/ajim.23028. Epub 2019 Jul 22.

PMID:
31328809
9.

Insights into pediatric rhabdomyosarcoma research: Challenges and goals.

Yohe ME, Heske CM, Stewart E, Adamson PC, Ahmed N, Antonescu CR, Chen E, Collins N, Ehrlich A, Galindo RL, Gryder BE, Hahn H, Hammond S, Hatley ME, Hawkins DS, Hayes MN, Hayes-Jordan A, Helman LJ, Hettmer S, Ignatius MS, Keller C, Khan J, Kirsch DG, Linardic CM, Lupo PJ, Rota R, Shern JF, Shipley J, Sindiri S, Tapscott SJ, Vakoc CR, Wexler LH, Langenau DM.

Pediatr Blood Cancer. 2019 Oct;66(10):e27869. doi: 10.1002/pbc.27869. Epub 2019 Jun 21. Review.

PMID:
31222885
10.

Male genital lichen sclerosus and filaggrin.

Shim TN, Brown SJ, Francis ND, Dinneen M, Hawkins D, Muneer A, Minhas S, Irwin McLean WH, Bunker CB.

Clin Exp Dermatol. 2019 Jun 17. doi: 10.1111/ced.14023. [Epub ahead of print] No abstract available.

PMID:
31206209
11.

Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group.

Casey DL, Chi YY, Donaldson SS, Hawkins DS, Tian J, Arndt CA, Rodeberg DA, Routh JC, Lautz TB, Gupta AA, Yock TI, Wolden SL.

Cancer. 2019 Sep 15;125(18):3242-3248. doi: 10.1002/cncr.32204. Epub 2019 Jun 7.

PMID:
31174239
12.

Exploring training dental implant placement using computer-guided implant navigation system for predoctoral students: A pilot study.

Golob Deeb J, Bencharit S, Carrico CK, Lukic M, Hawkins D, Rener-Sitar K, Deeb GR.

Eur J Dent Educ. 2019 Nov;23(4):415-423. doi: 10.1111/eje.12447. Epub 2019 Jun 13.

PMID:
31141291
13.

Laparoscopic Transabdominal Cerclage and Subsequent Pregnancy Outcomes When Left In Situ.

Ades A, Hawkins DP.

Obstet Gynecol. 2019 Jun;133(6):1195-1198. doi: 10.1097/AOG.0000000000003263.

PMID:
31135734
14.

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.

Bharathy N, Berlow NE, Wang E, Abraham J, Settelmeyer TP, Hooper JE, Svalina MN, Bajwa Z, Goros MW, Hernandez BS, Wolff JE, Pal R, Davies AM, Ashok A, Bushby D, Mancini M, Noakes C, Goodwin NC, Ordentlich P, Keck J, Hawkins DS, Rudzinski ER, Mansoor A, Perkins TJ, Vakoc CR, Michalek JE, Keller C.

Skelet Muscle. 2019 May 21;9(1):12. doi: 10.1186/s13395-019-0198-x.

15.

Laparoscopic Transabdominal Cerclage and Subsequent Pregnancy Outcomes When Left In Situ.

Ades A, Hawkins DP.

Obstet Gynecol. 2019 May 9. doi: 10.1097/AOG.0000000000003263. [Epub ahead of print]

PMID:
31083115
16.

Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.

Mascarenhas L, Lyden ER, Breitfeld PP, Walterhouse DO, Donaldson SS, Rodeberg DA, Parham DM, Anderson JR, Meyer WH, Hawkins DS.

Cancer. 2019 Aug 1;125(15):2602-2609. doi: 10.1002/cncr.32122. Epub 2019 May 8.

PMID:
31067356
17.
18.

Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.

Spunt SL, Francotte N, De Salvo GL, Chi YY, Zanetti I, Hayes-Jordan A, Kao SC, Orbach D, Brennan B, Weiss AR, van Noesel MM, Million L, Alaggio R, Parham DM, Kelsey A, Randall RL, McCarville MB, Bisogno G, Hawkins DS, Ferrari A.

Eur J Cancer. 2019 May;112:98-106. doi: 10.1016/j.ejca.2019.02.001. Epub 2019 Apr 5.

PMID:
30954717
19.

Factors influencing long-term weight loss after bariatric surgery.

Chang WW, Hawkins DN, Brockmeyer JR, Faler BJ, Hoppe SW, Prasad BM.

Surg Obes Relat Dis. 2019 Mar;15(3):456-461. doi: 10.1016/j.soard.2018.12.033. Epub 2019 Jan 9.

PMID:
30713118
20.

Penile fracture: Surgical vs. conservative treatment.

Ouellette L, Hamati M, Hawkins D, Bush C, Emery M, Jones J.

Am J Emerg Med. 2019 Feb;37(2):366-367. doi: 10.1016/j.ajem.2018.06.051. Epub 2018 Jun 22. No abstract available.

PMID:
30686331
21.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.

Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N.

Eur J Cancer. 2019 Mar;109:36-50. doi: 10.1016/j.ejca.2018.11.027. Epub 2019 Jan 25.

22.

Rhabdomyosarcoma.

Skapek SX, Ferrari A, Gupta AA, Lupo PJ, Butler E, Shipley J, Barr FG, Hawkins DS.

Nat Rev Dis Primers. 2019 Jan 7;5(1):1. doi: 10.1038/s41572-018-0051-2. Review.

PMID:
30617281
23.

Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors.

Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, DuBois SG, Vargas SO, Black JO, Cox MC, Luquette M, Turpin B, Szabo S, Laetsch TW, Albert CM, Parham DM, Hawkins DS, Rudzinski ER.

Am J Surg Pathol. 2019 Apr;43(4):435-445. doi: 10.1097/PAS.0000000000001203.

PMID:
30585824
24.

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models.

Lowery CD, Dowless M, Renschler M, Blosser W, VanWye AB, Stephens JR, Iversen PW, Lin AB, Beckmann RP, Krytska K, Cole KA, Maris JM, Hawkins DS, Rubin BP, Kurmasheva RT, Houghton PJ, Gorlick R, Kolb EA, Kang MH, Reynolds CP, Erickson SW, Teicher BA, Smith MA, Stancato LF.

Clin Cancer Res. 2019 Apr 1;25(7):2278-2289. doi: 10.1158/1078-0432.CCR-18-2728. Epub 2018 Dec 18.

PMID:
30563935
25.

The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma.

Bharathy N, Berlow NE, Wang E, Abraham J, Settelmeyer TP, Hooper JE, Svalina MN, Ishikawa Y, Zientek K, Bajwa Z, Goros MW, Hernandez BS, Wolff JE, Rudek MA, Xu L, Anders NM, Pal R, Harrold AP, Davies AM, Ashok A, Bushby D, Mancini M, Noakes C, Goodwin NC, Ordentlich P, Keck J, Hawkins DS, Rudzinski ER, Chatterjee B, Bächinger HP, Barr FG, Liddle J, Garcia BA, Mansoor A, Perkins TJ, Vakoc CR, Michalek JE, Keller C.

Sci Signal. 2018 Nov 20;11(557). pii: eaau7632. doi: 10.1126/scisignal.aau7632.

26.

Laser-heating system for high-pressure X-ray diffraction at the Extreme Conditions beamline I15 at Diamond Light Source.

Anzellini S, Kleppe AK, Daisenberger D, Wharmby MT, Giampaoli R, Boccato S, Baron MA, Miozzi F, Keeble DS, Ross A, Gurney S, Thompson J, Knap G, Booth M, Hudson L, Hawkins D, Walter MJ, Wilhelm H.

J Synchrotron Radiat. 2018 Nov 1;25(Pt 6):1860-1868. doi: 10.1107/S1600577518013383. Epub 2018 Oct 24.

27.

Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups.

Walterhouse DO, Barkauskas DA, Hall D, Ferrari A, De Salvo GL, Koscielniak E, Stevens MCG, Martelli H, Seitz G, Rodeberg DA, Shnorhavorian M, Dasgupta R, Breneman JC, Anderson JR, Bergeron C, Bisogno G, Meyer WH, Hawkins DS, Minard-Colin V.

J Clin Oncol. 2018 Oct 23:JCO2018789388. doi: 10.1200/JCO.2018.78.9388. [Epub ahead of print]

PMID:
30351998
28.

The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

Malempati S, Weigel BJ, Chi YY, Tian J, Anderson JR, Parham DM, Teot LA, Rodeberg DA, Yock TI, Shulkin BL, Spunt SL, Meyer WH, Hawkins DS.

Cancer. 2019 Jan 15;125(2):290-297. doi: 10.1002/cncr.31770. Epub 2018 Oct 23.

PMID:
30351457
29.

Larotrectinib for the treatment of TRK fusion solid tumors.

Laetsch TW, Hawkins DS.

Expert Rev Anticancer Ther. 2019 Jan;19(1):1-10. doi: 10.1080/14737140.2019.1538796. Epub 2018 Oct 24.

PMID:
30350734
30.

Genome-Informed Targeted Therapy for Osteosarcoma.

Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, Spillinger A, Shah AT, Tanasa B, Straessler K, Hazard FK, Spunt SL, Marina N, Kim GE, Cho SJ, Avedian RS, Mohler DG, Kim MO, DuBois SG, Hawkins DS, Sweet-Cordero EA.

Cancer Discov. 2019 Jan;9(1):46-63. doi: 10.1158/2159-8290.CD-17-1152. Epub 2018 Sep 28.

PMID:
30266815
31.

Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study.

Litton E, Baker S, Erber W, Farmer S, Ferrier J, French C, Gummer J, Hawkins D, Higgins A, Hofmann A, De Keulenaer B, McMorrow J, Olynyk JK, Richards T, Towler S, Trengove R, Webb S; IRONMAN Study investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group.

J Intensive Care. 2018 Sep 10;6:60. doi: 10.1186/s40560-018-0328-2. eCollection 2018.

32.

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.

DuBois SG, Laetsch TW, Federman N, Turpin BK, Albert CM, Nagasubramanian R, Anderson ME, Davis JL, Qamoos HE, Reynolds ME, Cruickshank S, Cox MC, Hawkins DS, Mascarenhas L, Pappo AS.

Cancer. 2018 Nov 1;124(21):4241-4247. doi: 10.1002/cncr.31701. Epub 2018 Sep 11.

33.

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

Whelan J, Le Deley MC, Dirksen U, Le Teuff G, Brennan B, Gaspar N, Hawkins DS, Amler S, Bauer S, Bielack S, Blay JY, Burdach S, Castex MP, Dilloo D, Eggert A, Gelderblom H, Gentet JC, Hartmann W, Hassenpflug WA, Hjorth L, Jimenez M, Klingebiel T, Kontny U, Kruseova J, Ladenstein R, Laurence V, Lervat C, Marec-Berard P, Marreaud S, Michon J, Morland B, Paulussen M, Ranft A, Reichardt P, van den Berg H, Wheatley K, Judson I, Lewis I, Craft A, Juergens H, Oberlin O; Euro-E.W.I.N.G.99 and EWING-2008 Investigators.

J Clin Oncol. 2018 Sep 6:JCO2018782516. doi: 10.1200/JCO.2018.78.2516. [Epub ahead of print]

34.

Desmoid tumours in children: when wait-and-see becomes wait-and-treat.

Weiss A, Hawkins D.

Lancet Child Adolesc Health. 2017 Dec;1(4):253-254. doi: 10.1016/S2352-4642(17)30070-6. Epub 2017 Sep 12. No abstract available.

PMID:
30169177
35.

Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Bradley JA, Kayton ML, Chi YY, Hawkins DS, Tian J, Breneman J, Wolden SL, Walterhouse D, Rodeberg DA, Donaldson SS.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):19-27. doi: 10.1016/j.ijrobp.2018.08.017. Epub 2018 Aug 20.

PMID:
30138647
36.

Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Hawkins DS, Chi YY, Anderson JR, Tian J, Arndt CAS, Bomgaars L, Donaldson SS, Hayes-Jordan A, Mascarenhas L, McCarville MB, McCune JS, McCowage G, Million L, Morris CD, Parham DM, Rodeberg DA, Rudzinski ER, Shnorhavorian M, Spunt SL, Skapek SX, Teot LA, Wolden S, Yock TI, Meyer WH.

J Clin Oncol. 2018 Sep 20;36(27):2770-2777. doi: 10.1200/JCO.2018.77.9694. Epub 2018 Aug 9.

37.

Penile lymphoedema: approach to investigation and management.

Shim TN, Doiron PR, Francis N, Minhas S, Muneer A, Hawkins D, Dinneen M, Bunker CB.

Clin Exp Dermatol. 2019 Jan;44(1):20-31. doi: 10.1111/ced.13609. Epub 2018 Jul 15.

PMID:
30009576
38.

Evaluation of applying statistical process control techniques to daily average feeding behaviors to detect disease in automatically fed group-housed preweaned dairy calves.

Knauer WA, Godden SM, Dietrich A, Hawkins DM, James RE.

J Dairy Sci. 2018 Sep;101(9):8135-8145. doi: 10.3168/jds.2017-13947. Epub 2018 Jul 13.

39.

Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes.

Xu L, Zheng Y, Liu J, Rakheja D, Singleterry S, Laetsch TW, Shern JF, Khan J, Triche TJ, Hawkins DS, Amatruda JF, Skapek SX.

Cell Rep. 2018 Jul 3;24(1):238-251. doi: 10.1016/j.celrep.2018.06.006.

40.

Trends in Weight Loss Efforts Among US Adolescents With Overweight and Obesity.

Hawkins DR, Kazmierski K, Hansen A, Reid C, Brown A, Opoku ST, Zhang J.

JAMA Pediatr. 2018 Aug 1;172(8):782-784. doi: 10.1001/jamapediatrics.2018.1012. No abstract available.

41.

Intermittent theta-burst stimulation for upper-limb dysfunction and spasticity in spinal cord injury: a single-blind randomized feasibility study.

Gharooni AA, Nair KPS, Hawkins D, Scivill I, Hind D, Hariharan R.

Spinal Cord. 2018 Aug;56(8):762-768. doi: 10.1038/s41393-018-0152-5. Epub 2018 Jun 12.

PMID:
29895874
42.

Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.

Minard-Colin V, Walterhouse D, Bisogno G, Martelli H, Anderson J, Rodeberg DA, Ferrari A, Jenney M, Wolden S, De Salvo G, Arndt C, Merks JHM, Gallego S, Schwob D, Haie-Meder C, Bergeron C, Stevens MCG, Oberlin O, Hawkins D; International Society of Pediatric Oncology Sarcoma Committee, the Children's Oncology Group, the Italian Cooperative Soft Tissue Sarcoma Group, and the European pediatric Soft tissue sarcoma Study Group.

Pediatr Blood Cancer. 2018 Sep;65(9):e27096. doi: 10.1002/pbc.27096. Epub 2018 May 21.

PMID:
29781567
43.

Trueness, precision and stability of the LIAISON 1-84 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays.

Valcour A, Zierold C, Blocki FA, Hawkins DM, Martin KJ, Rao SD, Bonelli F.

Clin Chem Lab Med. 2018 Aug 28;56(9):1476-1482. doi: 10.1515/cclm-2018-0217.

44.

Time Course of Blood Pressure Decrease After Bariatric Surgery in Normotensive and Hypertensive Patients.

Hawkins DN, Faler BJ, Choi YU, Prasad BM.

Obes Surg. 2018 Jul;28(7):1845-1851. doi: 10.1007/s11695-017-3091-x.

PMID:
29725978
45.

Accelerometer-based prediction of running injury in National Collegiate Athletic Association track athletes.

Kiernan D, Hawkins DA, Manoukian MAC, McKallip M, Oelsner L, Caskey CF, Coolbaugh CL.

J Biomech. 2018 May 17;73:201-209. doi: 10.1016/j.jbiomech.2018.04.001. Epub 2018 Apr 12.

46.

Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group.

Laetsch TW, Roy A, Xu L, Black JO, Coffin CM, Chi YY, Tian J, Spunt SL, Hawkins DS, Bridge JA, Parsons DW, Skapek SX.

Clin Cancer Res. 2018 Aug 15;24(16):3888-3897. doi: 10.1158/1078-0432.CCR-18-0672. Epub 2018 Apr 24.

47.

Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.

Ronsley R, Rassekh SR, Shen Y, Lee AF, Jantzen C, Halparin J, Albert C, Hawkins DS, Amed S, Rothstein R, Mungall AJ, Dix D, Blair G, Nadel H, Jones SJM, Laskin J, Marra MA, J Deyell R.

Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). pii: a002568. doi: 10.1101/mcs.a002568. Print 2018 Apr.

48.

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

Laetsch TW, DuBois SG, Mascarenhas L, Turpin B, Federman N, Albert CM, Nagasubramanian R, Davis JL, Rudzinski E, Feraco AM, Tuch BB, Ebata KT, Reynolds M, Smith S, Cruickshank S, Cox MC, Pappo AS, Hawkins DS.

Lancet Oncol. 2018 May;19(5):705-714. doi: 10.1016/S1470-2045(18)30119-0. Epub 2018 Mar 29. Erratum in: Lancet Oncol. 2018 May;19(5):e229.

49.

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM.

N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.

50.

Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.

Teot LA, Schneider M, Thorner AR, Tian J, Chi YY, Ducar M, Lin L, Wlodarski M, Grier HE, Fletcher CDM, van Hummelen P, Skapek SX, Hawkins DS, Wagers AJ, Rodriguez-Galindo C, Hettmer S.

Cancer. 2018 May 1;124(9):1973-1981. doi: 10.1002/cncr.31286. Epub 2018 Feb 20.

Supplemental Content

Loading ...
Support Center